The Food and Drug Administration rejected a bid from Elon Musk's human brain chips startup Neuralink to start human trials, according to Reuters.
Share:
More In Science
Hearing Aid Maker Eargo Sees Stock Price Double With Nasdaq IPO
Christian Gormsen, Eargo CEO, joined Cheddar to discuss the hearing aid company going public. and also about the path to expanding insurance coverage to include hearing aids.
Pfizer CEO Says Mid-November Earliest It Can Seek Coronavirus Vaccine OK
Pfizer CEO says it can't seek emergency authorization of its COVID-19 vaccine before the third week of November — and that's if everything goes well.
Calls to Avoid Broad Coronavirus Lockdowns Tests Limits of Scientific Debate
A trio of scientists is championing a controversial alternative to coronavirus lockdowns in a 500-word document called the Great Barrington Declaration, which is stirring up significant backlash from other public health experts.
Panera Leads Food Industry With Carbon Footprint Menu Labeling
Panera is doing its part to go green, upgrading its menu options to include the carbon footprint of each item. CEO Niren Chaudhary joined Cheddar to break down food production's link to climate change.
Isolation Doesn't Mean Loneliness, Says Astronaut Scott Kelly
Former NASA astronaut, Scott Kelly provides some insight into the impacts of being isolated, particularly as people around the world experience it amid the coronavirus pandemic.
Earth Breaks September Heat Record, May Reach Warmest Year
US Scientists calculate that Earth hit its warmest September on record last month. The National Oceanic and Atmospheric Administration Wednesday said there's nearly a two-to-one chance that 2020 will end up as the hottest year on record.
Extra Safety Scrutiny Planned as Coronavirus Vaccine Worries Grow
Facing public skepticism about rushed COVID-19 vaccines, U.S. health officials are planning an extra layer of safety scrutiny for the first people vaccinated when shots become available.
Johnson & Johnson Coronavirus Vaccine Trial Paused Over Unexplained Illness
A late-stage study of Johnson & Johnson’s COVID-19 vaccine candidate has been paused while the company investigates whether a study participant’s “unexplained illness” is related to the shot.
Coronavirus Adds More Challenges for Schoolkids Raised by Their Grandparents
At least 2 percent of American children are being raised by their grandparents, an arrangement that already has unique challenges for such families, but the COVID-19 pandemic is adding even more obstacles to contend with.
